ADAP
Adaptimmune Therapeutics
ADAP
ADAP
43 hedge funds and large institutions have $77.9M invested in Adaptimmune Therapeutics in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 13 closing their positions.
Holders
43
Holders Change
-6
Holders Change %
-12.24%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
12
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–